Ensysce Biosciences Inc (ENSC) — Financial Flexibility Index
Ensysce Biosciences Inc (ENSC) has a Financial Flexibility Index of -1.23x as of March 2026. Free cash flow of $-3.50 Million (operating CF $-3.50 Million minus capex $0.00) represents -1% of total liabilities ($2.84 Million). Check Ensysce Biosciences Inc strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ensysce Biosciences Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Ensysce Biosciences Inc across 9 annual periods. See ENSC working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Ensysce Biosciences Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Ensysce Biosciences Inc. For the full company profile including market capitalisation, see market value of Ensysce Biosciences Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1709009.42x | $-7.81 Trillion | $-7.81 Trillion | $4.57 Million | ▲ +49.5% |
| 2024 | -3383720.60x | $-7.50 Trillion | $-7.50 Trillion | $2.22 Million | ▼ -105446371.7% |
| 2023 | -3.21x | $-10.78 Million | $-10.78 Million | $3.36 Million | ▼ -77.9% |
| 2022 | -1.80x | $-17.89 Million | $-17.89 Million | $9.91 Million | ▼ -437.9% |
| 2021 | -0.34x | $-8.24 Million | $-8.24 Million | $24.58 Million | ▼ -88.5% |
| 2020 | -0.18x | $-1.25 Million | $-1.25 Million | $7.01 Million | ▼ -116.7% |
| 2019 | 1.06x | $10.99 Million | $10.99 Million | $10.34 Million | ▲ +739.0% |
| 2018 | -0.17x | $-1.24 Million | $-1.24 Million | $7.44 Million | ▼ -373.0% |
| 2017 | -0.04x | $-251.83K | $-251.83K | $7.16 Million | — |